New Pyridoquinoline Derivatives as Potential Inhibitors of the Fluoroquinolone Efflux Pump in Resistant Enterobacter aerogenes Strains
- 11 October 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (23), 4023-4026
- https://doi.org/10.1021/jm010911z
Abstract
Enterobacter aerogenes, one of the most frequently isolated nosocomial pathogens in France, is exhibiting increasing multidrug resistance mechanisms associated with a change in membrane permeability. For drugs of the quinolone family, mutations in the target and active efflux play a prominent role in the resistance. We report here the effect of several pyridoquinoline derivatives that restore a noticeable fluoroquinolone accumulation to resistant strains that overexpress the MarA activator. Studies of the energy-dependent quinolone efflux indicate that the most efficient derivatives tested probably inhibit the resistance process by acting as substrate competitors on the pump extruding intracellular norfloxacin.Keywords
This publication has 24 references indexed in Scilit:
- In Vivo Modification of Porin Activity Conferring Antibiotic Resistance to Enterobacter aerogenesBiochemical and Biophysical Research Communications, 1999
- Inhibitors of Efflux Pumps in Pseudomonas aeruginosa Potentiate the Activity of the Fluoroquinolone Antibacterial LevofloxacinJournal of Medicinal Chemistry, 1999
- Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenesMicrobiology, 1998
- Multidrug resistance in enteric and other Gram-negative bacteriaFEMS Microbiology Letters, 1996
- Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coliMicrobiology, 1995
- Resistance to Antibiotics Mediated by Target AlterationsScience, 1994
- Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active EffluxScience, 1994
- Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclinesJournal of Medicinal Chemistry, 1993
- Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenesJournal of Antimicrobial Chemotherapy, 1990
- Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacaeAntimicrobial Agents and Chemotherapy, 1985